Regression of systemic lupus erythematosus after development of an acquired toll-like receptor signaling defect and antibody deficiency.
暂无分享,去创建一个
F. Tinti | M. Fiorilli | I. Quinti | M. Visentini | A. P. Mitterhofer | V. Conti | A. Trombetta | M. Cagliuso | G. Siciliano | Valentina Conti | Giulia Siciliano | A. Mitterhofer
[1] Uri Hershberg,et al. T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells. , 2008, Immunity.
[2] M. Cimmino,et al. Is FDG-PET useful in the evaluation of steroid-resistant PMR patients? , 2008, Rheumatology.
[3] G. Tsokos,et al. Common variable immune deficiency (CVID) presenting as an autoimmune disease: role of memory B cells. , 2008, Autoimmunity reviews.
[4] L. Joosten,et al. The orchestra of Toll-like receptors and their potential role in frequently occurring rheumatic conditions. , 2008, Arthritis and rheumatism.
[5] I. Olivieri,et al. Cervical interspinous bursitis in active polymyalgia rheumatica , 2008, Annals of the rheumatic diseases.
[6] Nichole E Carlson,et al. Duration of humoral immunity to common viral and vaccine antigens. , 2007, The New England journal of medicine.
[7] D. Isenberg,et al. B cell depletion therapy in systemic lupus erythaematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response , 2007 .
[8] J. Andreu,et al. Common variable immunodeficiency in systemic lupus erythematosus. , 2007, Seminars in arthritis and rheumatism.
[9] D. Isenberg,et al. B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles. , 2006, Arthritis and rheumatism.
[10] J. Shupe,et al. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. , 2006, Immunity.
[11] A. Lanzavecchia,et al. Toll‐like receptor stimulation as a third signal required for activation of human naive B cells , 2006, European journal of immunology.
[12] C. Cunningham-Rundles,et al. TLR9 Activation Is Defective in Common Variable Immune Deficiency1 , 2006, The Journal of Immunology.
[13] S. Akira,et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement , 2005, The Journal of experimental medicine.
[14] S. Akira,et al. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus , 2005, The Journal of experimental medicine.
[15] M. Shlomchik,et al. Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors , 2002, Nature.
[16] A. B. Lyons,et al. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. , 2000, Journal of immunological methods.
[17] A. B. Lyons,et al. B cell differentiation and isotype switching is related to division cycle number , 1996, The Journal of experimental medicine.
[18] C. Salvarani,et al. Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica. Quantitative analysis and influence of corticosteroid treatment. , 1996, Arthritis and rheumatism.
[19] Eren,et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. , 2008, Blood.
[20] D. Isenberg,et al. B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response. , 2008, Annals of the rheumatic diseases.